Operating income decreased 34.6%
Operating income changed -34.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -34.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating margin changed -218 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Net income changed -47.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -41.1% from the comparable as-filed period.
Revenue changed +5.6% from the comparable as-filed period.
SBC / revenue changed -89 basis points from the comparable as-filed period.
Stock-based compensation changed -15.9% from the comparable as-filed period.
Research & development changed -2.2% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.